Par Drugs and Chemicals Ltd
NSE:PAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Par Drugs and Chemicals Ltd (PAR) under the Base Case is 111.82 INR per share.
Compared with the current market price of 118.11 INR, the stock appears
Overvalued by 5% .
The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about 10% a year over the next five years, against 11% over the last five, and net margin stays near last year's 13%. If revenue grew at its five-year pace of 11%, the estimate would be about ₹124.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Par Drugs and Chemicals Does
Par Drugs and Chemicals makes pharmaceutical ingredients and chemical intermediates that are used to produce medicines. Its products sit early in the drug supply chain, so it sells mainly to other pharma companies rather than directly to patients. The company also serves customers that need custom-made chemical batches for specific drug formulas.
- Headquarters
- India IN
- IPO date
- May 16, 2019
Earnings Waterfall
Par Drugs and Chemicals Ltd
What is the Intrinsic Value of one PAR stock?
The intrinsic value for
Par Drugs and Chemicals Ltd (PAR) under the Base Case is 111.82 INR.
Is PAR stock undervalued or overvalued?
Compared with the current market price of 118.11 INR, the stock appears Overvalued by 5% .